NTS-105 Decreases Cell Death After In Vitro Stretch Injury
In this poster presentation, NeuroTrauma Sciences reports data on its novel neuroactive small molecule NTS-105. This study demonstrates the ability of NTS-105 to reduce cell death at a wide range of concentrations in preclinical models of TBI. This research was conducted by a research team led by Barclay Morrison, III, Ph.D., Professor of Biomedical Engineering at Columbia University, New York, NY.
Comments are closed.